Immunomodulatory effect of mesenchymal stromal cells: possible mechanisms (Q37202800)

18 August 2017

1 reference

title

Immunomodulatory effect of mesenchymal stromal cells: possible mechanisms (English)

1 reference

18 August 2017

A Nasef

1

1 reference

PubMed ID

18588475

18 August 2017

N Ashammakhi

series ordinal

2

1 reference

PubMed ID

18588475

18 August 2017

L Fouillard

series ordinal

3

1 reference

18 August 2017

1 July 2008

1 reference

18 August 2017

Regenerative Medicine

1 reference

18 August 2017

3

1 reference

18 August 2017

531-546

1 reference

18 August 2017

4

1 reference

Multilineage potential of adult human mesenchymal stem cells

18 August 2017

1 reference

https://api.crossref.org/works/10.2217%2F17460751.3.4.531

Isolation and characterization of bone marrow multipotential mesenchymal progenitor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460751.3.4.531

Clarification of the nomenclature for MSC: The International Society for Cellular Therapy position statement.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460751.3.4.531

Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460751.3.4.531

Cell surface antigens on human marrow-derived mesenchymal cells are detected by monoclonal antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460751.3.4.531

Marrow stromal cells as stem cells for nonhematopoietic tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460751.3.4.531

Autologous mesenchymal stem cell-mediated repair of tendon

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460751.3.4.531

Unexpected potential of adult stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460751.3.4.531

Marrow stromal cells migrate throughout forebrain and cerebellum, and they differentiate into astrocytes after injection into neonatal mouse brains

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460751.3.4.531

Cultured adherent cells from marrow can serve as long-lasting precursor cells for bone, cartilage, and lung in irradiated mice

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460751.3.4.531

Human mesenchymal stem cells support unrelated donor hematopoietic stem cells and suppress T-cell activation

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460751.3.4.531

Dynamic of distribution of human bone marrow-derived mesenchymal stem cells after transplantation into adult unconditioned mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460751.3.4.531

Mesenchymal stem cells promote engraftment of human umbilical cord blood-derived CD34(+) cells in NOD/SCID mice

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460751.3.4.531

Engraftment of a clonal bone marrow stromal cell line in vivo stimulates hematopoietic recovery from total body irradiation

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460751.3.4.531

Allogeneic mesenchymal stem cell infusion for treatment of metachromatic leukodystrophy (MLD) and Hurler syndrome (MPS-IH).

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460751.3.4.531

Adipose tissue-derived mesenchymal stem cells have in vivo immunosuppressive properties applicable for the control of the graft-versus-host disease

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460751.3.4.531

Reversal of the immunosuppressive properties of mesenchymal stem cells by tumor necrosis factor alpha in collagen-induced arthritis.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460751.3.4.531

Mesenchymal stem cells suppress lymphocyte proliferation in vitro and prolong skin graft survival in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460751.3.4.531

Cotransplantation of marrow stromal cells may prevent lethal graft-versus-host disease in major histocompatibility complex mismatched murine hematopoietic stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460751.3.4.531

Mesenchymal stem cells enhance xenochimerism in NK-depleted hosts.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460751.3.4.531

Mesenchymal stem cells ameliorate experimental autoimmune encephalomyelitis inducing T-cell anergy.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460751.3.4.531

Cell therapy using allogeneic bone marrow mesenchymal stem cells prevents tissue damage in collagen-induced arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460751.3.4.531

Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460751.3.4.531

Bone marrow mesenchymal stromal cells (BM-MSCs) from healthy donors and auto-immune disease patients reduce the proliferation of autologous- and allogeneic-stimulated lymphocytes in vitro.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460751.3.4.531

Cotransplantation of third-party mesenchymal stromal cells can alleviate single-donor predominance and increase engraftment from double cord transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460751.3.4.531

No alloantibodies against mesenchymal stromal cells, but presence of anti-fetal calf serum antibodies, after transplantation in allogeneic hematopoietic stem cell recipients.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460751.3.4.531

Suppression of allogeneic T-cell proliferation by human marrow stromal cells: implications in transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460751.3.4.531

Immunologic properties of human fetal mesenchymal stem cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460751.3.4.531

Concise review: mesenchymal stem cells: their phenotype, differentiation capacity, immunological features, and potential for homing.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460751.3.4.531

Mesenchymal stem cells inhibit the expression of CD25 (interleukin-2 receptor) and CD38 on phytohaemagglutinin-activated lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460751.3.4.531

Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460751.3.4.531

Bone marrow mesenchymal stem cells inhibit the response of naive and memory antigen-specific T cells to their cognate peptide.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460751.3.4.531

Antigen-presenting property of mesenchymal stem cells occurs during a narrow window at low levels of interferon-gamma

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460751.3.4.531

Veto-Like Activity of Mesenchymal Stem Cells: Functional Discrimination Between Cellular Responses to Alloantigens and Recall Antigens

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460751.3.4.531

Effects of human mesenchymal stem cells on the differentiation of dendritic cells from CD34+ cells

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460751.3.4.531

Human mesenchymal stem cells license adult CD34+ hemopoietic progenitor cells to differentiate into regulatory dendritic cells through activation of the Notch pathway.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460751.3.4.531

Effects of mesenchymal stem cells on differentiation, maturation, and function of human monocyte-derived dendritic cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460751.3.4.531

Human mesenchymal stem cells alter antigen-presenting cell maturation and induce T-cell unresponsiveness

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460751.3.4.531

Human mesenchymal stem cells modulate allogeneic immune cell responses

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460751.3.4.531

Characterization and functionality of cell surface molecules on human mesenchymal stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460751.3.4.531

Toll-like receptors on human mesenchymal stem cells drive their migration and immunomodulating responses

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460751.3.4.531

Mesenchymal stem cells inhibit lymphocyte proliferation by mitogens and alloantigens by different mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460751.3.4.531

Allogeneic mesenchymal stem cell and mesenchymal stem cell-differentiated chondrocyte suppress the responses of type II collagen-reactive T cells in rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460751.3.4.531

Bone marrow mesenchymal progenitor cells inhibit lymphocyte proliferation by activation of the programmed death 1 pathway.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460751.3.4.531

Human mesenchymal stem cells modulate B-cell functions

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460751.3.4.531

Mesenchymal stem cells stimulate antibody secretion in human B cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460751.3.4.531

Immunomodulatory effects of fetal and adult mesenchymal stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460751.3.4.531

Human leukocyte antigen-G5 secretion by human mesenchymal stem cells is required to suppress T lymphocyte and natural killer function and to induce CD4+CD25highFOXP3+ regulatory T cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460751.3.4.531

Mesenchymal stem cells as trophic mediators

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460751.3.4.531

Gene expression profile of cytokine and growth factor during differentiation of bone marrow-derived mesenchymal stem cell

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460751.3.4.531

A paradoxical role for IFN-gamma in the immune properties of mesenchymal stem cells during viral challenge

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460751.3.4.531

Interferon-gamma does not break, but promotes the immunosuppressive capacity of adult human mesenchymal stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460751.3.4.531

Mesenchymal stem cells inhibit the differentiation of dendritic cells through an interleukin-6-dependent mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460751.3.4.531

Human mesenchymal stem cells inhibit neutrophil apoptosis: a model for neutrophil preservation in the bone marrow niche

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460751.3.4.531

Mesenchymal stem cells fail to trigger effector functions of cytotoxic T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460751.3.4.531

Human bone marrow stromal cells inhibit allogeneic T-cell responses by indoleamine 2,3-dioxygenase-mediated tryptophan degradation

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460751.3.4.531

Mesenchymal stem cells induce apoptosis of activated T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460751.3.4.531

Expanded adipose-derived stem cells suppress mixed lymphocyte reaction by secretion of prostaglandin E2.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460751.3.4.531

Human mesenchymal stem cells induce T cell anergy and downregulate T cell allo-responses via the TH2 pathway: relevance to tissue engineering human heart valves.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460751.3.4.531

Biology of natural killer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460751.3.4.531

Interactions between human mesenchymal stem cells and natural killer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460751.3.4.531

Mesenchymal stem cell-natural killer cell interactions: evidence that activated NK cells are capable of killing MSCs, whereas MSCs can inhibit IL-2-induced NK-cell proliferation.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460751.3.4.531

The veto phenomenon in T-cell regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460751.3.4.531

Mesenchymal stem cells inhibit proliferation and apoptosis of tumor cells: impact on in vivo tumor growth.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460751.3.4.531

Human mesenchymal stem cells exert potent antitumorigenic effects in a model of Kaposi's sarcoma

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460751.3.4.531

Prophylaxis against carcinogenesis in three kinds of unestablished tumor models via IL12-gene-engineered MSCs

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460751.3.4.531

Human mesenchymal stem cells (hMSCs) expressing truncated soluble vascular endothelial growth factor receptor (tsFlk-1) following lentiviral-mediated gene transfer inhibit growth of Burkitt's lymphoma in a murine model.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460751.3.4.531

Earlier onset of syngeneic tumors in the presence of mesenchymal stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460751.3.4.531

Isolated allogeneic bone marrow-derived mesenchymal cells engraft and stimulate growth in children with osteogenesis imperfecta: Implications for cell therapy of bone

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460751.3.4.531

Adhesion of hematopoietic progenitor cells to human mesenchymal stem cells as a model for cell−cell interaction

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460751.3.4.531

Reconstitution with syngeneic plus allogeneic or xenogeneic bone marrow leads to specific acceptance of allografts or xenografts

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460751.3.4.531

Bone marrow mesenchymal stem cells induce division arrest anergy of activated T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460751.3.4.531

21 January 2018

Identifiers

DOI

10.2217/17460751.3.4.531

1 reference

18 August 2017

1 reference

PubMed ID

18588475